Cambridge Healthtech Institute’s 2nd Annual

Single-Cell Multiomics

Single-Cell Transcriptomics, Genomics, Proteomics, and Metabolomics

March 27-28, 2024

Single-cell analysis of genomic, epigenomic, transcriptomic, proteomic, and metabolomic data promises to enable the next frontier in systems biology. Multi-omic profiling at single-cell resolution transforms our understanding of biology and cellular heterogeneity and facilitates new target and biomarker discovery and the advancement of precision medicine. CHI’s 2^nd Annual Single-Cell Multiomics meeting will cover technologies for single-cell multiomic profiling and data interpretation, and its applications in drug development and translational research.

Coverage will include, but is not limited to:

Applications in cancer biology and precision medicine
Single-cell transcriptomics and single-cell genomics
Machine learning and AI for single-cell multiomics data analysis
Advances in spatial transcriptomics
Single-cell epigenome profiling
Single-cell proteomics and metabolomics
Systems biology and single-cell analysis
Single-cell immune profiling
Data integration strategies
Identifying rare cell types
Characterizing cancer heterogeneity
Studying immune system and crosstalk with various tissues

The deadline for priority consideration is September 1, 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: